Severe lower back pain often leads to the diagnosis of kidney stones. While surgery can remove the stones, many people ...
Eli Lilly signed a collaboration and licensing agreement worth up to $1.9 billion with Ascidian Therapeutics to research and ...
They had ‘highly sensitized’ immune systems that usually reject donated organs, leaving them with few options for survival.
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results